Humacyte, Inc.
HUMA
$0.57
-$0.01-1.80%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -64.91% | -25.65% | 72.54% | 75.82% | 58.00% |
| Total Depreciation and Amortization | -1.14% | 1.00% | 2.16% | 2.08% | 1.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.72% | 114.77% | -211.79% | -218.73% | -202.26% |
| Change in Net Operating Assets | -23.95% | -229.54% | -7,622.51% | -395.88% | -204.90% |
| Cash from Operations | 6.99% | -2.18% | -7.05% | -16.44% | -29.49% |
| Capital Expenditure | 79.53% | 41.02% | 43.77% | 45.27% | -47.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 79.53% | 41.02% | 43.77% | 45.27% | -47.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 43.23% | 20.69% | -8.53% | -13.47% | -13.85% |
| Issuance of Common Stock | 34.63% | -11.90% | 16.50% | 143.80% | 133.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25,958.53% | -14,480.16% | -558.68% | -351.91% | -101.78% |
| Cash from Financing | -11.24% | -61.21% | -46.15% | -11.97% | 64.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.97% | -2,319.41% | -406.72% | -73.66% | 73.26% |